934240-30-9,MFCD22580419
Catalog No.:AA00GU5G

934240-30-9 | 2-Pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98+%
in stock  
$43.00   $30.00
- +
5mg
98+%
in stock  
$109.00   $76.00
- +
10mg
98+%
in stock  
$184.00   $129.00
- +
25mg
98+%
in stock  
$312.00   $219.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GU5G
Chemical Name:
2-Pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-
CAS Number:
934240-30-9
Molecular Formula:
C18H19FN2O2
Molecular Weight:
314.3541
MDL Number:
MFCD22580419
SMILES:
NC(=O)[C@@H]1CC[C@@H](N1)c1ccc(cc1)OCc1ccccc1F
Properties
Computed Properties
 
Complexity:
399  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
2.4  

Upstream Synthesis Route

[1]Patent:WO2016/102967,2016,A1,.Locationinpatent:Page/Pagecolumn41

[2]Patent:WO2007/42239,2007,A1,.Locationinpatent:Page/Pagecolumn43-44

[3]Patent:WO2008/90114,2008,A1,.Locationinpatent:Page/Pagecolumn30

[4]Patent:WO2008/90114,2008,A1,.Locationinpatent:Page/Pagecolumn30

[1]Patent:WO2011/29762,2011,A1,

[1]Patent:WO2011/29762,2011,A1,

[1]Patent:WO2011/29762,2011,A1,

[1]Patent:WO2011/29762,2011,A1,

Downstream Synthesis Route

[1]Patent:WO2016/102967,2016,A1.Locationinpatent:Page/Pagecolumn41

[2]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn43-44

[3]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn30

[4]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn30

[1]Patent:WO2016/102967,2016,A1.Locationinpatent:Page/Pagecolumn43

[2]Patent:WO2011/29762,2011,A1.Locationinpatent:Page/Pagecolumn23-24

[3]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn45

[4]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn45-46

[5]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn46

[6]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn31

[7]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn31-32

[8]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn32

[9]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn32-33

[1]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn48-49

[1]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn33

[1]Patent:WO2011/29762,2011,A1

Literature

Title: The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.

Journal: The Journal of pharmacology and experimental therapeutics 20110701

Title: Large CH, et al. The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia. J Pharmacol Exp Ther. 2011 Jul;338(1):100-13.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 934240-30-9
Tags:934240-30-9 Molecular Formula|934240-30-9 MDL|934240-30-9 SMILES|934240-30-9 2-Pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-
Catalog No.: AA00GU5G
934240-30-9,MFCD22580419
934240-30-9 | 2-Pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-
Pack Size: 1mg
Purity: 98+%
in stock
$43.00 $30.00
Pack Size: 5mg
Purity: 98+%
in stock
$109.00 $76.00
Pack Size: 10mg
Purity: 98+%
in stock
$184.00 $129.00
Pack Size: 25mg
Purity: 98+%
in stock
$312.00 $219.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GU5G
Chemical Name: 2-Pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-
CAS Number: 934240-30-9
Molecular Formula: C18H19FN2O2
Molecular Weight: 314.3541
MDL Number: MFCD22580419
SMILES: NC(=O)[C@@H]1CC[C@@H](N1)c1ccc(cc1)OCc1ccccc1F
Properties
Complexity: 399  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 5  
XLogP3: 2.4  
Upstream Synthesis Route
934240-62-7    934240-30-9 

[1]Patent:WO2016/102967,2016,A1,.Locationinpatent:Page/Pagecolumn41

[2]Patent:WO2007/42239,2007,A1,.Locationinpatent:Page/Pagecolumn43-44

[3]Patent:WO2008/90114,2008,A1,.Locationinpatent:Page/Pagecolumn30

[4]Patent:WO2008/90114,2008,A1,.Locationinpatent:Page/Pagecolumn30

446-48-0    934240-30-9 

[1]Patent:WO2011/29762,2011,A1,

99-76-3    934240-30-9 

[1]Patent:WO2011/29762,2011,A1,

1272317-41-5    934240-30-9 

[1]Patent:WO2011/29762,2011,A1,

1272317-42-6    934240-30-9 

[1]Patent:WO2011/29762,2011,A1,

Downstream Synthesis Route
934240-62-7    934240-30-9 

[1]Patent:WO2016/102967,2016,A1.Locationinpatent:Page/Pagecolumn41

[2]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn43-44

[3]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn30

[4]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn30

934240-30-9    934240-31-0 

[1]Patent:WO2016/102967,2016,A1.Locationinpatent:Page/Pagecolumn43

[2]Patent:WO2011/29762,2011,A1.Locationinpatent:Page/Pagecolumn23-24

[3]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn45

[4]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn45-46

[5]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn46

[6]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn31

[7]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn31-32

[8]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn32

[9]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn32-33

934240-30-9    934240-35-4 

[1]Patent:WO2007/42239,2007,A1.Locationinpatent:Page/Pagecolumn48-49

75-75-2    934240-30-9    934240-35-4 

[1]Patent:WO2008/90114,2008,A1.Locationinpatent:Page/Pagecolumn33

446-48-0    934240-30-9 

[1]Patent:WO2011/29762,2011,A1

Literature fold

Title: The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.

Journal: The Journal of pharmacology and experimental therapeutics20110701

Title: Large CH, et al. The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia. J Pharmacol Exp Ther. 2011 Jul;338(1):100-13.

Building Blocks More >
890007-12-2
890007-12-2
3-(4-METHYLPHENYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID
AA00GU9G | MFCD03030169
871478-79-4
871478-79-4
4-Amino-5-[(2,6-dichlorophenoxy)methyl]-4h-1,2,4-triazole-3-thiol
AA00GUCX | MFCD07366410
916982-10-0
916982-10-0
4-(2-Methylpropyl)piperidine-2,6-dione
AA00GUK3 | MFCD18277013
89379-40-8
89379-40-8
N(1),N(1),2-Trimethylpropane-1,2-diamine hydrochloride
AA00GURJ | MFCD00269646
89429-59-4
89429-59-4
2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol
AA00GV2I | MFCD15144655
932233-33-5
932233-33-5
Pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidin-6(7H)-one
AA00GVCV | MFCD09438567
938350-35-7
938350-35-7
2-(3,4-Dihydroisoquinolin-2(1h)-yl)propanoic acid
AA00GVI2 | MFCD09717484
878160-14-6
878160-14-6
3-Amino-4-methoxy-N-methylbenzamide
AA00GVM9 | MFCD09049030
915921-40-3
915921-40-3
N-(2-Bromobenzyl)propanamide
AA00GVQY | MFCD08569830
887405-23-4
887405-23-4
1-(3-Methylimidazo[2,1-b][1,3]thiazol-6-yl)methanamine
AA00GVVF | MFCD09971795
Submit
© 2017 AA BLOCKS, INC. All rights reserved.